Skip to main content
. 2014 Jan 29;306(7):R447–R456. doi: 10.1152/ajpregu.00520.2013

Fig. 4.

Fig. 4.

Effect of glibenclamide to inhibit KATP channels on OT (A) and VP (B) release from HNS explants in 1 mM glucose. Glibenclamide increased OT and VP release (OT: *, **, ***P < 0.05, 0.01, and 0.001, respectively, by Bonferroni post hoc analysis; VP: *P < 0.05 by post hoc t-test).